Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Hypertension

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 56 articles:
HTML format



Single Articles


    December 2023
  1. JAUREGUI R, Busis NA
    Idiopathic Intracranial Hypertension.
    N Engl J Med. 2023;389:2467.
    PubMed    


    November 2023
  2. BARIS FELDMAN H, Chai Gadot C, Zahler D, Mory A, et al
    Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.
    N Engl J Med. 2023;389:1685-1692.
    PubMed     Abstract available


    October 2023
  3. DESAI AS, Sweetser MT, Bakris GL
    Zilebesiran for Hypertension. Reply.
    N Engl J Med. 2023;389:1439-1440.
    PubMed    


  4. VAN TWIST DJL, Kalic H
    Zilebesiran for Hypertension.
    N Engl J Med. 2023;389:1438-1439.
    PubMed    


  5. LIFSCHITZ M
    Zilebesiran for Hypertension.
    N Engl J Med. 2023;389:1438.
    PubMed    


  6. ABASHEVA D, Fernandez-Fernandez B, Ortiz A
    Zilebesiran for Hypertension.
    N Engl J Med. 2023;389:1438.
    PubMed    


    July 2023
  7. TOUYZ RM
    Silencing Angiotensinogen in Hypertension.
    N Engl J Med. 2023;389:278-281.
    PubMed    


  8. DESAI AS, Webb DJ, Taubel J, Casey S, et al
    Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension.
    N Engl J Med. 2023;389:228-238.
    PubMed     Abstract available


    May 2023
  9. FREEMAN MW, Halvorsen YD, Brown MJ
    Baxdrostat for Treatment-Resistant Hypertension. Reply.
    N Engl J Med. 2023;388:1821-1822.
    PubMed    


  10. FISK M
    Baxdrostat for Treatment-Resistant Hypertension.
    N Engl J Med. 2023;388:1821.
    PubMed    


  11. D'ALLESANDRO N, Hough A, Parra D
    Baxdrostat for Treatment-Resistant Hypertension.
    N Engl J Med. 2023;388:1820-1821.
    PubMed    


  12. KIDA Y
    Baxdrostat for Treatment-Resistant Hypertension.
    N Engl J Med. 2023;388:1820.
    PubMed    


  13. SIMMONS D, Immanuel J, Hague WM, Teede H, et al
    Treatment of Gestational Diabetes Mellitus Diagnosed Early in Pregnancy.
    N Engl J Med. 2023 May 5. doi: 10.1056/NEJMoa2214956.
    PubMed     Abstract available


    April 2023
  14. ISHANI A, Cushman WC, Leatherman SM
    Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events. Reply.
    N Engl J Med. 2023;388:1342.
    PubMed    


  15. FRAVEL MA, Ernst ME
    Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events.
    N Engl J Med. 2023;388:1342.
    PubMed    


  16. MESSERLI FH
    Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events.
    N Engl J Med. 2023;388:1341-1342.
    PubMed    


    March 2023
  17. HOEPER MM, Badesch DB, Ghofrani HA, Gibbs JSR, et al
    Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension.
    N Engl J Med. 2023 Mar 6. doi: 10.1056/NEJMoa2213558.
    PubMed     Abstract available


  18. TAICHMAN DB, Leopold JA, Elliott G
    Continued Progress in Therapy for Pulmonary Arterial Hypertension.
    N Engl J Med. 2023 Mar 6. doi: 10.1056/NEJMe2300324.
    PubMed    


    February 2023
  19. LEOPOLD JA, Ingelfinger JR
    Aldosterone and Treatment-Resistant Hypertension.
    N Engl J Med. 2023;388:464-467.
    PubMed    


  20. AZIZI M
    Decreasing the Effects of Aldosterone in Resistant Hypertension - A Success Story.
    N Engl J Med. 2023;388:461-463.
    PubMed    


    December 2022
  21. INGELFINGER JR
    Thiazide-like versus Thiazide Diuretics - Finally, an Answer?
    N Engl J Med. 2022;387:2462-2463.
    PubMed    


  22. ISHANI A, Cushman WC, Leatherman SM, Lew RA, et al
    Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events.
    N Engl J Med. 2022 Dec 14. doi: 10.1056/NEJMoa2212270.
    PubMed     Abstract available


    November 2022
  23. FREEMAN MW, Halvorsen YD, Marshall W, Pater M, et al
    Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension.
    N Engl J Med. 2022 Nov 7. doi: 10.1056/NEJMoa2213169.
    PubMed     Abstract available


    September 2022
  24. NATHAN DM, Lachin JM, Bebu I, Burch HB, et al
    Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes.
    N Engl J Med. 2022;387:1075-1088.
    PubMed     Abstract available


    August 2022
  25. TITA AT, Szychowski JM, Andrews WW
    Treatment for Mild Chronic Hypertension during Pregnancy. Reply.
    N Engl J Med. 2022;387:664.
    PubMed    


  26. MAGEE LA, von Dadelszen P
    Treatment for Mild Chronic Hypertension during Pregnancy.
    N Engl J Med. 2022;387:664.
    PubMed    


  27. GLEESON PJ, O'Seaghdha CM
    Treatment for Mild Chronic Hypertension during Pregnancy.
    N Engl J Med. 2022;387:663-664.
    PubMed    


    April 2022
  28. AGARWAL R, Sinha AD, Tu W
    Chlorthalidone for Hypertension in Advanced CKD. Reply.
    N Engl J Med. 2022;386:1384.
    PubMed    


  29. AFSAR B, Kanbay M, Elsurer Afsar R
    Chlorthalidone for Hypertension in Advanced CKD.
    N Engl J Med. 2022;386:1383-1384.
    PubMed    


  30. ELIAS R, Zatz R
    Chlorthalidone for Hypertension in Advanced CKD.
    N Engl J Med. 2022;386:1382-1383.
    PubMed    


  31. LINDNER G, Ravioli S
    Chlorthalidone for Hypertension in Advanced CKD.
    N Engl J Med. 2022;386:1382.
    PubMed    


  32. GREENE MF, Williams WW
    Treating Hypertension in Pregnancy.
    N Engl J Med. 2022 Apr 2. doi: 10.1056/NEJMe2203388.
    PubMed    


  33. TITA AT, Szychowski JM, Boggess K, Dugoff L, et al
    Treatment for Mild Chronic Hypertension during Pregnancy.
    N Engl J Med. 2022 Apr 2. doi: 10.1056/NEJMoa2201295.
    PubMed     Abstract available


    February 2022
  34. ELLISON DH, Welling P
    Insights into Salt Handling and Blood Pressure. Reply.
    N Engl J Med. 2022;386:e18.
    PubMed    


  35. JOHNSON RJ, Lanaspa MA, Rodriguez-Iturbe B
    Insights into Salt Handling and Blood Pressure.
    N Engl J Med. 2022;386:e18.
    PubMed    


  36. HU B, Li W, Zhou H
    Insights into Salt Handling and Blood Pressure.
    N Engl J Med. 2022;386:e18.
    PubMed    


  37. MIN A, Ditkofsky N
    Page Kidneys.
    N Engl J Med. 2022;386:673.
    PubMed    


    December 2021
  38. DENG Y, Bai J, Cai J
    Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension. Reply.
    N Engl J Med. 2021;385:2590-2591.
    PubMed    


  39. MAGGIANI GSG, Bo M
    Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension.
    N Engl J Med. 2021;385:2590.
    PubMed    


  40. STEFFEN HM, Bonner G, Middeke M
    Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension.
    N Engl J Med. 2021;385:2589-2590.
    PubMed    


  41. CHU PJ
    Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension.
    N Engl J Med. 2021;385:2589.
    PubMed    


  42. OSAWA S, Mori J
    Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension.
    N Engl J Med. 2021;385:2588-2589.
    PubMed    


  43. HASSOUN PM
    Pulmonary Arterial Hypertension.
    N Engl J Med. 2021;385:2361-2376.
    PubMed    


    November 2021
  44. POLI F, Yusuf IH
    Retinopathy in Malignant Hypertension.
    N Engl J Med. 2021;385:1994.
    PubMed    


  45. ELLISON DH, Welling P
    Insights into Salt Handling and Blood Pressure.
    N Engl J Med. 2021;385:1981-1993.
    PubMed    


  46. AGARWAL R, Sinha AD, Cramer AE, Balmes-Fenwick M, et al
    Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease.
    N Engl J Med. 2021 Nov 5. doi: 10.1056/NEJMoa2110730.
    PubMed     Abstract available


    September 2021
  47. SANDBORN WJ, Feagan BG, D'Haens G, Wolf DC, et al
    Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
    N Engl J Med. 2021;385:1280-1291.
    PubMed     Abstract available


  48. FANG M, Selvin E
    Diabetes Treatment and Control in U.S. Adults. Reply.
    N Engl J Med. 2021;385:e30.
    PubMed    


  49. SHOAG JE, Al Hussein Al Awamlh B, Rajagopalan S
    Diabetes Treatment and Control in U.S. Adults.
    N Engl J Med. 2021;385:e30.
    PubMed    


  50. BRUNO S, Roosevelt TS
    Diabetes Treatment and Control in U.S. Adults.
    N Engl J Med. 2021;385:e30.
    PubMed    


    August 2021
  51. ZHANG W, Zhang S, Deng Y, Wu S, et al
    Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension.
    N Engl J Med. 2021 Aug 30. doi: 10.1056/NEJMoa2111437.
    PubMed     Abstract available


  52. NEAL B, Wu Y, Feng X, Zhang R, et al
    Effect of Salt Substitution on Cardiovascular Events and Death.
    N Engl J Med. 2021 Aug 29. doi: 10.1056/NEJMoa2105675.
    PubMed     Abstract available


    July 2021
  53. BJORNSTAD P, Drews KL, Caprio S, Gubitosi-Klug R, et al
    Long-Term Complications in Youth-Onset Type 2 Diabetes.
    N Engl J Med. 2021;385:416-426.
    PubMed     Abstract available


    June 2021
  54. LAU ES, Scirica B, Schaefer IM, Miller AL, et al
    Hypertensive Heartbreak.
    N Engl J Med. 2021;384:2145-2152.
    PubMed    


    May 2021
  55. LAU ES, Vaidya A, Schaefer IM, Scirica BM, et al
    Hypertensive Heartbreak.
    N Engl J Med. 2021;384:e80.
    PubMed    


  56. LEWIS CE, Fine LJ, Beddhu S, Cheung AK, et al
    Final Report of a Trial of Intensive versus Standard Blood-Pressure Control.
    N Engl J Med. 2021;384:1921-1930.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.